Cardiopulmonary exercise testing demonstrates maintenance of exercise capacity in patients with hypoxemia and pulmonary arteriovenous malformations

Chest

Volumn 146, Issue 3, 2014, Pages 709-718

  Howard, Luke S G E ^a   Santhirapala, Vatshalan ^a,b,c,d   Murphy, Kevin ^b   Mukherjee, Bhashkar ^a   Busbridge, Mark ^a   Tighe, Hannah C ^b   Jackson, James E ^a   Hughes, J Michael B ^b,c   Shovlin, Claire L ^b  

^a IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE;

ADULT; AGED; AMBIENT AIR; ANAEROBIC THRESHOLD; ARTERIAL OXYGEN SATURATION; ARTICLE; ARTIFICIAL EMBOLISM; BODY MASS; BREATHING; CARDIOPULMONARY EXERCISE TEST; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPNEA; EXERCISE TOLERANCE; FEMALE; HEART BEAT; HEART WORK; HUMAN; HYPOXEMIA; LUNG MINUTE VOLUME; MALE; OXYGEN CONSUMPTION; OXYGENATION; PULMONARY ARTERIOVENOUS FISTULA; ANOXIA; ARTERIOVENOUS FISTULA; CASE CONTROL STUDY; ENDURANCE; EXERCISE TEST; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PULMONARY ARTERY; PULMONARY VEIN;

AGED; ANAEROBIC THRESHOLD; ANOXIA; ARTERIOVENOUS FISTULA; BODY MASS INDEX; CARBON DIOXIDE; CASE-CONTROL STUDIES; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PHYSICAL ENDURANCE; PULMONARY ARTERY; PULMONARY VEINS;

EID: 84903622689     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-2988     Document Type: Article

References (40)

1. Shovlin CL, Jackson JE. Pulmonary arteriovenous malformations and other vascular abnormalities. In: Mason RJ, Broaddus VC, Martin T, et al, eds. Murray and Nadel's Textbook of Respiratory Medicine. 5th ed. Philadelphia, PA: Elsevier-Saunders; 2010: 1261-1282.
2. Nakayama M, Nawa T, Chonan T, et al. Prevalence of pulmonary arteriovenous malformations as estimated by low-dose thoracic CT screening. Intern Med. 2012; 51 (13): 1677-1681.
3. Terry PB, White RI Jr, Barth KH, Kaufman SL, Mitchell SE. Pulmonary arteriovenous malformations. Physiologic observations and results of therapeutic balloon embolization. N Engl J Med. 1983; 308 (20): 1197-1200.
4. Chilvers ER, Peters AM, George P, Hughes JM, Allison DJ. Quantifi cation of right to left shunt through pulmonary arteriovenous malformations using 99Tcm albumin microspheres. Clin Radiol. 1988; 39 (6): 611-614.
5. Whyte MK, Peters AM, Hughes JM, et al. Quantifi cation of right to left shunt at rest and during exercise in patients with pulmonary arteriovenous malformations. Thorax. 1992; 47 (10): 790-796.
6. Pennington DW, Gold WM, Gordon RL, Steiger D, Ring EJ, Golden JA. Treatment of pulmonary arteriovenous malformations by therapeutic embolization. Rest and exercise physiology in eight patients. Am Rev Respir Dis. 1992; 145 (5): 1047-1051.
7. Whyte MK, Hughes JM, Jackson JE, et al. Cardiopulmonary response to exercise in patients with intrapulmonary vascular shunts. J Appl Physiol (1985). 1993; 75 (1): 321-328.
8. Ueki J, Hughes JM, Peters AM, et al. Oxygen and 99m Tc-MAA shunt estimations in patients with pulmonary arteriovenous malformations: effects of changes in posture and lung volume. Thorax. 1994; 49 (4): 327-331.
9. Mager JJ, Zanen P, Verzijlbergen F, et al. Quantifi cation of right-to-left shunt with (99m)Tc-labelled albumin macroaggregates and 100% oxygen in patients with hereditary haemorrhagic telangiectasia. Clin Sci (Lond). 2002; 102 (2): 127-134.
10. Cottin V, Chinet T, Lavolé A, et al; Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). Pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: a series of 126 patients. Medicine (Baltimore). 2007; 86 (1): 1-17.
11. Shovlin CL, Jackson JE, Bamford KB, et al. Primary determinants of ischaemic stroke/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia. Thorax. 2008; 63 (3): 259-266.
12. Shovlin CL, Tighe HC, Davies RJ, Gibbs JS, Jackson JE. Embolisation of pulmonary arteriovenous malformations: no consistent effect on pulmonary artery pressure. Eur Respir J. 2008; 32 (1): 162-169.
13. Mason CG, Shovlin CL. Flight-related complications are infrequent in patients with hereditary haemorrhagic telangiectasia/pulmonary arteriovenous malformations, despite low oxygen saturations and anaemia. Thorax. 2012; 67 (1): 80-81.
14. West JB. High Life: A History of High-Altitude Physiology and Medicine. New York, NY: Oxford Univ Press; 1998.
15. Hughes JMB. Physiology and Practice of Pulmonary function. ARTP. Boldmere, England: Association for Respiratory Technology and Physiology; 2009.
16. Evans AM, Hardie DG, Peers C, Mahmoud A. Hypoxic pulmonary vasoconstriction: mechanisms of oxygen-sensing. Curr Opin Anaesthesiol. 2011; 24 (1): 13-20.
17. Guttmacher AE, Marchuk DA, White RI Jr. Hereditary hemorrhagic telangiectasia. N Engl J Med. 1995; 333 (14): 918-924.
18. Shovlin CL. Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev. 2010; 24 (6): 203-219.
19. Olivieri C, Lanzarini L, Pagella F, et al. Echocardiographic screening discloses increased values of pulmonary artery systolic pressure in 9 of 68 unselected patients affected with hereditary hemorrhagic telangiectasia. Genet Med. 2006; 8 (3): 183-190.
20. Sopeña B, Pérez-Rodríguez MT, Portela D, Rivera A, Freire M, Martínez-Vázquez C. High prevalence of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. Eur J Intern Med. 2013; 24 (3): e30-e34.
21. Trembath RC, Thomson JR, Machado RD, et al. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med. 2001; 345 (5): 325-334.
22. Harrison RE, Flanagan JA, Sankelo M, et al. Molecular and functional analysis identifi es ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia. J Med Genet. 2003; 40 (12): 865-871.
23. Smoot LB, Obler D, McElhinney DB, et al. Clinical features of pulmonary arterial hypertension in young people with an ALK1 mutation and hereditary haemorrhagic telangiectasia. Arch Dis Child. 2009; 94 (7): 506-511.
24. Girerd B, Montani D, Coulet F, et al. Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation. Am J Respir Crit Care Med. 2010; 181 (8): 851-861.
25. Boillot O, Bianco F, Viale JP, et al. Liver transplantation resolves the hyperdynamic circulation in hereditary hemorrhagic telangiectasia with hepatic involvement. Gastroenterology. 1999; 116 (1): 187-192.
26. Lerut J, Orlando G, Adam R, et al; European Liver Transplant Association. Liver transplantation for hereditary hemorrhagic telangiectasia: report of the European liver transplant registry. Ann Surg. 2006; 244 (6): 854-862.
27. Ginon I, Decullier E, Finet G, et al. Hereditary hemorrhagic telangiectasia, liver vascular malformations and cardiac consequences. Eur J Intern Med. 2013; 24 (3): e35-e39.
28. Santhirapala V, Williams LC, Tighe H, Jackson JE, Shovlin CL. Arterial oxygen content is precisely maintained by graded erythrocytotic responses in settings of high/normal serum iron levels, and predicts exercise capacity: an observational study of hypoxaemic patients with pulmonary arteriovenous malformations. PLoS One. 2014;9(3):e90777.
29. Shovlin CL, Chamali B, Santhirapala V, et al. Ischaemic strokes in patients with pulmonary arteriovenous malformations and hereditary hemorrhagic defi ciency and platelets. PLoS One. 2014; 9 (2): e88812.
30. Burdon JGW, Juniper EF, Killian KJ, Hargreave FE, Campbell EJ. The perception of breathlessness in asthma. Am Rev Respir Dis. 1982; 126 (5): 825-828.
31. Hansen JE, Sue DY, Wasserman K. Predicted values for clinical exercise testing. Am Rev Respir Dis. 1984; 129 (2 pt 2): S49-S55.
32. Mezzani A, Agostoni P, Cohen-Solal A, et al. Standards for the use of cardiopulmonary exercise testing for the functional evaluation of cardiac patients: a report from the Exercise Physiology Section of the European Association for Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil. 2009; 16 (3): 249-267.
33. Koch B, Schäper C, Ittermann T, et al. Reference values for cardiopulmonary exercise testing in healthy volunteers: the SHIP study. Eur Respir J. 2009; 33 (2): 389-397.
34. Pittman RN. Chapter 4, oxygen transport. In: Pittman RN, ed. Regulation of Tissue Oxygenation. San Rafael, CA: Morgan & Claypool Life Sciences; 2011.
35. Hart JL, Aldin Z, Braude P, Shovlin CL, Jackson J. Embolization of pulmonary arteriovenous malformations using the Amplatzer vascular plug: successful treatment of 69 consecutive patients. Eur Radiol. 2010; 20 (11): 2663-2670.
36. Zhai Z, Murphy K, Tighe H, et al. Diff erences in ventilatory ineffi ciency between pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Chest. 2011; 140 (5): 1284-1291.
37. Santhirapala V, Chamali B, McKernan H, et al. Orthodeoxia and postural orthostatic tachycardia in patients with pulmonary arteriovenous malformations: a prospective 8-year series [published online ahead of print April 8, 2014]. Thorax. doi:10.1136/thoraxjnl-2014-205289.
38. McAllister DA, Maclay JD, Mills NL, et al. Diagnosis of myocardial infarction following hospitalisation for exacerbation of COPD. Eur Respir J. 2012; 39 (5): 1097-1103.
39. Søyseth V, Bhatnagar R, Holmedahl NH, et al. Acute exacerbation of COPD is associated with fourfold elevation of cardiac troponin T. Heart. 2013; 99 (2): 122-126.
40. Smith GB, Prytherch DR, Watson D, et al. S(p)O(2) values in acute medical admissions breathing air-implications for the British Thoracic Society guideline for emergency oxygen use in adult patients? Resuscitation. 2012; 83 (10): 1201-1205.